chr7-107710175-G-C
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 3P and 4B. PM1PP2BP4_Strong
The NM_000441.2(SLC26A4):c.2211G>C(p.Glu737Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000126 in 1,606,602 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E737V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000441.2 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive nonsyndromic hearing loss 4Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- Pendred syndromeInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), ClinGen
- athyreosisInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- thyroid hypoplasiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hearing loss, autosomal recessiveInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000441.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC26A4 | NM_000441.2 | MANE Select | c.2211G>C | p.Glu737Asp | missense | Exon 19 of 21 | NP_000432.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC26A4 | ENST00000644269.2 | MANE Select | c.2211G>C | p.Glu737Asp | missense | Exon 19 of 21 | ENSP00000494017.1 | ||
| SLC26A4 | ENST00000492030.2 | TSL:5 | n.397G>C | non_coding_transcript_exon | Exon 4 of 6 | ||||
| SLC26A4 | ENST00000644846.1 | n.*113G>C | non_coding_transcript_exon | Exon 8 of 10 | ENSP00000494344.1 |
Frequencies
GnomAD3 genomes AF: 0.000296 AC: 45AN: 152162Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000203 AC: 51AN: 251276 AF XY: 0.000214 show subpopulations
GnomAD4 exome AF: 0.000108 AC: 157AN: 1454322Hom.: 1 Cov.: 27 AF XY: 0.000117 AC XY: 85AN XY: 724020 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000302 AC: 46AN: 152280Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74466 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Pendred syndrome Uncertain:3
The variant is observed at an extremely low frequency in the gnomAD v4.1.0 dataset (total allele frequency: 0.013%). Predicted Consequence/Location: Missense variant The same nucleotide change resulting in the same amino acid change has been previously reported to be associated with SLC26A4-related disorder (PMID: 19509082). However, the evidence of pathogenicity is insufficient at this time. Therefore, this variant is classified as VUS according to the recommendation of ACMG/AMP guideline.
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com.
not provided Uncertain:2Benign:1
SLC26A4: PM2, BP4
Published functional studies demonstrate a damaging effect on protein function (PMID: 19509082); In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 19509082, 34426522, 30245029, 26990548)
not specified Uncertain:1
The p.Glu737Asp variant in SLC26A4 has been previously reported in four individu als with hearing loss, one of whom had no inner ear abnormalities. It was not re ported for the remaining three individuals whether or not inner ear abnormalitie s were present (Dai 2009, LMM unpublished data). All these individuals were hete rozygous for this variant and a second pathogenic variant was not identified. Th is variant has been identified in 17/111562 European chromosomes by the Genome A ggregation Database (gnomAD, http://http://gnomad.broadinstitute.org; dbSNP rs20 0664061); however this frequency is not high enough to rule out a pathogenic rol e. A functional study reported that the p.Glu737Asp variant, when expressed in X enopus oocytes, had a reduced rate of Cl(-)/HCO(3)(-) exchange (Dai 2009), thoug h this in vitro assay may not accurately represent biological function. Computat ional prediction tools and conservation analyses suggest that the Glu737Asp vari ant may not impact the protein, though this information is not predictive enough to rule out pathogenicity. In summary, the clinical significance of the p.Glu73 7Asp variant is uncertain.
Autosomal recessive nonsyndromic hearing loss 4 Uncertain:1
Hearing impairment Uncertain:1
PM2_Supporting, BP4_Supporting
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at